
Jeffrey R. Binder, MD
Professor of Neurology, Cell Biology, Neurobiology and Anatomy, and Biophysics; Director of Stroke and Neurobehavior Programs, Department of Neurology; Director of Language Imaging Laboratory, Department of Neurology
Locations
- 91ɫƵ
Department of Neurology
Contact Information
Education
Biography
Resident, Neurology, The Neurological Institute of New York, Presbyterian Hospital; New York, NY, 1987-1990
Fellow, Stroke and Behavioral Neurology, The Neurological Institute of New York, Presbyterian Hospital; New York, NY, 1990-1992
Societies
American Academy of Neurology, 1987
American Association for the Advancement of Science, 1993
International Society for Magnetic Resonance in Medicine, 1995
Society for Neuroscience, 1995
World Federation of Neurology - Research Group on Aphasia and Cognitive Disorders, 1996
Cognitive Neuroscience Society, 1997
Honors and Awards
Phi Beta Kappa, 1980
Regents Scholarship, University of Nebraska Medical Center, 1983
Michaelson Student Research Grant, University of Nebraska Medical Center, 1985
Alpha Omega Alpha, 1985
Research Interests
"Functional MRI of Human Brain Language Systems," NINDS RO1 NS33576-06 (J.R. Binder, P.I.).
"Functional Magnetic Resonance Imaging During Auditory Language Processing," McDonnell-Pew Program in Cognitive Neuroscience, Grant No. 92-35. Total Direct Costs (1993-1995). 20% effort; Principal Investigator.
"Effects of Stimulus Rate, Intensity, and Duration on Functional Magnetic Resonance Signal Response," 91ɫƵ Research Affairs Committee, Grant No. 1093-11. Total funding. Principal Investigator.
"Natural History of Neurobehavioral Dysfunction in MS," National Multiple Sclerosis Society Grant (S.M. Rao, P.I.). Total Direct Costs (1994-1997). 5% effort; Co-Investigator.
"Pre-surgical Localization of Language and Memory Cortex with Functional MRI," Charles A. Dana Foundation Clinical Hypotheses in Neuroscience Research Program. Direct Costs (1994-1997). 14% effort; Principal Investigator.
"A Multicenter, Double-Blind, Placebo-Controlled, Dose-Finding Efficacy Study of CNS 1102 in Patients with Acute Cerebral Ischemia," Cambridge Neuroscience, Inc. Total local costs (1995). 5% effort; Local Principal Investigator.
"Phase II/III Multicenter, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Two Doses of Intravenous Aptiganel Hydrochloride versus Placebo in Patients with Acute Ischemic Stroke," Boehringer Ingelheim, Inc. Total local costs (1996-1997). 5% effort; Local Principal Investigator.
"Clomethiazole Acute Stroke Study (CLASS-I, II, III)," Astra Pharmaceuticals, Inc. (Co-Investigator).
Specialties and Subspecialties
Adult Neurology
Aphasia
Behavioral Neurology
Cerebrovascular Disease
Neuroimaging
Neuropsychology